首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal MLH3 Antibody

  • 中文名: MLH3抗体
  • 别    名: DNA mismatch repair protein Mlh3; MutL protein homolog 3;
货号: IPDX42213
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesDNA mismatch repair protein Mlh3; MutL protein homolog 3;
Entrez GeneID27030;
WB Predicted band size164kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthesized peptide derived from internal of human MLH3.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于MLH3抗体的3篇参考文献概览(基于公开研究整理):

---

1. **文献名称**:*Germline mutations of the DNA mismatch repair gene MLH3 in patients with hereditary non-polyposis colorectal cancer*

**作者**:Wu Y, et al.

**摘要**:研究利用MLH3抗体进行免疫组化分析,发现携带MLH3生殖细胞突变的林奇综合征患者中,MLH3蛋白表达显著缺失,提示其与结直肠癌遗传易感性相关。

2. **文献名称**:*MLH3 mutations in endometrial cancer*

**作者**:Hienonen T, et al.

**摘要**:通过Western blot和免疫荧光技术结合MLH3抗体,发现子宫内膜癌组织中MLH3蛋白功能异常可能与错配修复缺陷及微卫星不稳定性有关。

3. **文献名称**:*Mlh3 deficiency in mice triggers defects in DNA repair and increased tumor susceptibility*

**作者**:Lipkin SM, et al.

**摘要**:利用MLH3抗体检测基因敲除小鼠模型,证实Mlh3缺失导致DNA修复功能受损,并显著提高淋巴瘤和肠癌发生率,支持其在基因组稳定性中的作用。

---

(注:若需具体文献,建议通过PubMed或学术数据库检索DOI或PMID获取全文。)

背景信息

The MLH3 antibody is a crucial tool in studying the MLH3 protein, a component of the DNA mismatch repair (MMR) system. MLH3. a member of the MutL homolog family, forms heterodimers with MLH1 to participate in correcting DNA replication errors, particularly during meiosis. It plays a role in maintaining genomic stability and is implicated in hereditary cancers, notably Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC), where MLH3 mutations may contribute to microsatellite instability (MSI) and tumorigenesis. MLH3 antibodies are widely used in research to detect protein expression via techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). These applications help investigate MMR deficiency, assess cancer risk, and validate MLH3's interaction partners. Antibodies targeting specific domains (e.g., C-terminal) are often validated using knockout cell lines to ensure specificity. Beyond research, MLH3 antibodies hold diagnostic potential in profiling MMR status in tumors, aiding Lynch syndrome screening. However, MLH3's functional overlap with other MutL proteins (e.g., PMS2) requires careful interpretation of results. Ongoing studies explore its role beyond MMR, including apoptosis and immune response, highlighting its broader biomedical relevance.

客户数据及评论

折叠内容

大包装询价

×